You have free access to this content

Hepatology

Cover image for Hepatology

January 2010

Volume 51, Issue 1

Pages 1–358

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation (pages 23–34)

      José A. Carrión, Ferran Torres, Gonzalo Crespo, Rosa Miquel, Juan-Carlos García-Valdecasas, Miquel Navasa and Xavier Forns

      Version of Record online: 18 OCT 2009 | DOI: 10.1002/hep.23240

    2. You have free access to this content
    3. You have free access to this content
      Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles (pages 43–53)

      Wagane J. A. Benga, Sophie E. Krieger, Maria Dimitrova, Mirjam B. Zeisel, Marie Parnot, Joachim Lupberger, Eberhard Hildt, Guangxiang Luo, John McLauchlan, Thomas F. Baumert and Catherine Schuster

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23278

    4. You have free access to this content
      Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope (pages 54–62)

      Christoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, Nadine Kersting, Karen Fitzmaurice, Cesar Oniangue-Ndza, Michael N. Kemper, Isla Humphreys, Susan McKiernan, Dermot Kelleher, Volker Lohmann, Paul Bowness, Daniela Huzly, Hugo R. Rosen, Arthur Y. Kim, Georg M. Lauer, Todd M. Allen, Eleanor Barnes, Michael Roggendorf, Hubert E. Blum and Robert Thimme

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23275

    5. You have free access to this content
      Control of hepatitis B virus replication by innate response of HepaRG cells (pages 63–72)

      Julie Lucifora, David Durantel, Barbara Testoni, Olivier Hantz, Massimo Levrero and Fabien Zoulim

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23230

    6. You have free access to this content
      Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues (pages 73–80)

      Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer, Katja Deterding, Jörg Petersen, Peter Buggisch, Andreas Erhardt, Dietrich Hüppe, Kerstin Stein, Jörg Trojan, Christoph Sarrazin, Wulf O. Böcher, Ulrich Spengler, Hermann E. Wasmuth, Jurrien G.P. Reinders, Bernd Möller, Peter Rhode, Heinz-Hubert Feucht, Bertram Wiedenmann and Thomas Berg

      Version of Record online: 25 AUG 2009 | DOI: 10.1002/hep.23246

    7. You have free access to this content
      Interleukin-17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B (pages 81–91)

      Ji-Yuan Zhang, Zheng Zhang, Fang Lin, Zheng-Sheng Zou, Ruo-Nan Xu, Lei Jin, Jun-Liang Fu, Feng Shi, Ming Shi, Hui-Fen Wang and Fu-Sheng Wang

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23273

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Major histocompatibility complex class I–related chains A and B (MIC A/B): A novel role in nonalcoholic steatohepatitis (pages 92–102)

      Alisan Kahraman, Martin Schlattjan, Peri Kocabayoglu, Sule Yildiz-Meziletoglu, Matthias Schlensak, Christian D. Fingas, Inga Wedemeyer, Guido Marquitan, Robert K. Gieseler, Hideo A. Baba, Guido Gerken and Ali Canbay

      Version of Record online: 8 DEC 2009 | DOI: 10.1002/hep.23253

    2. You have free access to this content
      Increased tumor necrosis factor α–converting enzyme activity induces insulin resistance and hepatosteatosis in mice (pages 103–110)

      Loredana Fiorentino, Alessia Vivanti, Michele Cavalera, Valeria Marzano, Maurizio Ronci, Marta Fabrizi, Stefano Menini, Giuseppe Pugliese, Rossella Menghini, Rama Khokha, Renato Lauro, Andrea Urbani and Massimo Federici

      Version of Record online: 25 AUG 2009 | DOI: 10.1002/hep.23250

    3. You have free access to this content
      Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease (pages 111–120)

      Lauren N. Bell, Janice L. Theodorakis, Raj Vuppalanchi, Romil Saxena, Kerry G. Bemis, Mu Wang and Naga Chalasani

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23271

    4. You have free access to this content
      Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis (pages 121–129)

      Kittichai Promrat, David E. Kleiner, Heather M. Niemeier, Elizabeth Jackvony, Marie Kearns, Jack R. Wands, Joseph L. Fava and Rena R. Wing

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23276

    5. You have free access to this content
      Kupffer cell and interleukin-12–dependent loss of natural killer T cells in hepatosteatosis (pages 130–141)

      Michael Kremer, Emmanuel Thomas, Richard J. Milton, Ashley W. Perry, Nico van Rooijen, Michael D. Wheeler, Steven Zacks, Michael Fried, Richard A. Rippe and Ian N. Hines

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23292

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
    2. You have free access to this content
      Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells (pages 154–164)

      Dong-Ming Kuang, Chen Peng, Qiyi Zhao, Yan Wu, Min-Shan Chen and Limin Zheng

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23291

    3. You have free access to this content
      Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety (pages 165–173)

      Alessandro Vitale, Michael L. Volk, Davide Pastorelli, Sara Lonardi, Fabio Farinati, Patrizia Burra, Paolo Angeli and Umberto Cillo

      Version of Record online: 31 AUG 2009 | DOI: 10.1002/hep.23260

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis (pages 174–180)

      Sanjay Y. Bangarulingam, Einar Bjornsson, Felicity Enders, Emily G. Barr Fritcher, Gregory Gores, Kevin C. Halling and Keith D. Lindor

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23277

    2. You have free access to this content
      Mouse organic solute transporter α deficiency enhances renal excretion of bile acids and attenuates cholestasis (pages 181–190)

      Carol J. Soroka, Albert Mennone, Lee R. Hagey, Nazzareno Ballatori and James L. Boyer

      Version of Record online: 4 SEP 2009 | DOI: 10.1002/hep.23265

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Liver injury in acute fatty liver of pregnancy: Possible link to placental mitochondrial dysfunction and oxidative stress (pages 191–200)

      Sathish Kumar Natarajan, Kavitha R. Thangaraj, C. E. Eapen, Anup Ramachandran, Ashis Mukhopadhya, Mathews Mathai, Lakshmi Seshadri, Abraham Peedikayil, Banumathi Ramakrishna and Kunnissery A. Balasubramanian

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23245

    2. You have free access to this content
      Increased caffeine consumption is associated with reduced hepatic fibrosis (pages 201–209)

      Apurva A. Modi, Jordan J. Feld, Yoon Park, David E. Kleiner, James E. Everhart, T. Jake Liang and Jay H. Hoofnagle

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23279

    3. You have free access to this content
      Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study (pages 210–218)

      Aurelie Plessier, Sarwa Darwish-Murad, Manuel Hernandez-Guerra, Yann Consigny, Federica Fabris, Jonel Trebicka, Jorg Heller, Isabelle Morard, Luc Lasser, Philippe Langlet, Marie-Hélène Denninger, Dominique Vidaud, Bertrand Condat, Antoine Hadengue, Massimo Primignani, Juan-Carlos Garcia-Pagan, Harry L. A. Janssen, Dominique Valla and European Network for Vascular Disorders of the Liver (EN-Vie)

      Version of Record online: 31 AUG 2009 | DOI: 10.1002/hep.23259

  8. Liver Failure, Cirrhosis and Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome (pages 219–226)

      André Nazar, Gustavo Henrique Pereira, Mónica Guevara, Marta Martín-Llahi, Marie-Noëlle Pepin, Marcella Marinelli, Elsa Solá, María Eugenia Baccaro, Carlos Terra, Vicente Arroyo and Pere Ginès

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23283

  9. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation (pages 227–236)

      Rick D. Fannin, Mark Russo, Thomas M. O'Connell, Kevin Gerrish, Jason H. Winnike, Jeffrey Macdonald, Jack Newton, Shahid Malik, Stella O. Sieber, Joel Parker, Ruchir Shah, Tong Zhou, Paul B. Watkins and Richard S. Paules

      Version of Record online: 25 SEP 2009 | DOI: 10.1002/hep.23330

  10. Liver Injury and Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice (pages 237–245)

      Yosuke Osawa, Ekihiro Seki, Masayuki Adachi, Atsushi Suetsugu, Hiroyasu Ito, Hisataka Moriwaki, Mitsuru Seishima and Masahito Nagaki

      Version of Record online: 31 AUG 2009 | DOI: 10.1002/hep.23262

  11. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
  12. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression (pages 255–266)

      Rosa Quiles-Perez, José Antonio Muñoz-Gámez, Ángeles Ruiz-Extremera, Francisco O'Valle, Laura Sanjuán-Nuñez, Ana Belén Martín-Álvarez, David Martín-Oliva, Trinidad Caballero, Paloma Muñoz de Rueda, Josefa León, Raúl Gonzalez, Jordi Muntané, Francisco Javier Oliver and Javier Salmerón

      Version of Record online: 25 AUG 2009 | DOI: 10.1002/hep.23249

  13. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4−/− mice (pages 267–276)

      Martin Roderfeld, Timo Rath, Robert Voswinckel, Christian Dierkes, Hartmut Dietrich, Daniel Zahner, Jürgen Graf and Elke Roeb

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23274

  14. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Mechanisms for increased expression of cholesterol 7α-hydroxylase (Cyp7a1) in lactating rats (pages 277–285)

      Clavia Ruth Wooton-Kee, Donna J. Coy, Antony T. Athippozhy, Tianyong Zhao, Brett R. Jones and Mary Vore

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23289

    2. You have free access to this content
      Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate (pages 286–296)

      Lieke M. van der Velden, Janneke M. Stapelbroek, Elmar Krieger, Peter V. E. van den Berghe, Ruud Berger, Patricia M. Verhulst, Joost C. M. Holthuis, Roderick H. J. Houwen, Leo W. J. Klomp and Stan F. J. van de Graaf

      Version of Record online: 4 SEP 2009 | DOI: 10.1002/hep.23268

    3. You have free access to this content
      Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells (pages 297–305)

      Karim Si-Tayeb, Fallon K. Noto, Masato Nagaoka, Jixuan Li, Michele A. Battle, Christine Duris, Paula E. North, Stephen Dalton and Stephen A. Duncan

      Version of Record online: 1 OCT 2009 | DOI: 10.1002/hep.23354

  15. AASLD Practice Guidelines

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
    2. You have free access to this content
      Alcoholic liver disease (pages 307–328)

      Robert S. O'Shea, Srinivasan Dasarathy, Arthur J. McCullough and Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology

      Version of Record online: 31 AUG 2009 | DOI: 10.1002/hep.23258

  16. Rapid Communication

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Generation of functional human hepatic endoderm from human induced pluripotent stem cells (pages 329–335)

      Gareth J. Sullivan, David C. Hay, In-Hyun Park, Judy Fletcher, Zara Hannoun, Catherine M. Payne, Donna Dalgetty, James R. Black, James A. Ross, Kay Samuel, Gang Wang, George Q. Daley, Je-Hyuk Lee, George M. Church, Stuart J. Forbes, John P. Iredale and Ian Wilmut

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23335

  17. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
    2. You have free access to this content
  18. Image of the Month

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      A case of fulminant hepatic failure in pregnancy (pages 341–342)

      John Halliday, Julie Lokan, Peter W. Angus and Paul Gow

      Version of Record online: 13 OCT 2009 | DOI: 10.1002/hep.23372

  19. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
    2. You have free access to this content
      Reply: (pages 343–344)

      Kathleen E. Corey and Raymond T. Chung

      Version of Record online: 27 OCT 2009 | DOI: 10.1002/hep.23413

    3. You have free access to this content
    4. You have free access to this content
      Reply: (page 345)

      Leen Delang and Johan Neyts

      Version of Record online: 3 NOV 2009 | DOI: 10.1002/hep.23414

    5. You have free access to this content
    6. You have free access to this content
      Reply: (page 346)

      Ian N. Hines

      Version of Record online: 13 NOV 2009 | DOI: 10.1002/hep.23434

    7. You have free access to this content
      Minocycline sensitizes rodent and human liver mitochondria to the permeability transition: Implications for toxicity in liver transplantation (pages 347–348)

      Roland Månsson, Saori Morota, Magnus J. Hansson, Ichiro Sonoda, Yoshihiro Yasuda, Motohide Shimazu, Ayumu Sugiura, Shigeru Yanagi, Hitoshi Miura, Hiroyuki Uchino and Eskil Elmér

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23465

    8. You have free access to this content
      Minocycline protects against the mitochondria permeability transition after both warm and cold ischemia-reperfusion (pages 349–350)

      Xun Zhang, Justin Schwartz, Venkat K. Ramshesh, Peter Pediaditakis, Ekhson Holmuhamedov, Zhi Zhong, Tom P. Theruvath and John J. Lemasters

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23453

    9. You have free access to this content
    10. You have free access to this content
      Reply: (page 351)

      Michael A. Heneghan and Andrew D. Yeoman

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23482

    11. You have free access to this content
    12. You have free access to this content
      Statins and hepatitis C virus: Friend or foe? (page 352)

      Enzo Emanuele

      Version of Record online: 20 MAY 2009 | DOI: 10.1002/hep.23087

    13. You have free access to this content
      Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells (page 353)

      Michelina Nascimbeni, Thomas Montange, Helen K. W. Law, Vincent Mallet, Bertrand Saunier, Yves Rivière and Stanislas Pol

      Version of Record online: 13 JUL 2009 | DOI: 10.1002/hep.23165

    14. You have free access to this content
      Protection of mitochondrial genome integrity: A new stem cell property? (page 354)

      Malcolm R. Alison, Stuart A. C. McDonald, Wey Ran Lin and Nicholas A. Wright

      Version of Record online: 20 JUL 2009 | DOI: 10.1002/hep.23171

    15. You have free access to this content
      Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C (pages 354–355)

      Mohammed Rashid, Jonathon D. Mitchell, Matthew E. Cramp and Timothy J. S. Cross

      Version of Record online: 20 JUL 2009 | DOI: 10.1002/hep.23185

    16. You have free access to this content
      Is it difficult to obtain an optimal liver biopsy specimen? (pages 355–356)

      Evangelos Cholongitas and Andrew K. Burroughs

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23236

    17. You have free access to this content
      The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C (pages 356–357)

      Pierre Pradat, Eric Trepo, Andrej Potthoff, Rakesh Bakshi, Bradford Young, Christian Trepo, Robert Lagier, Christophe Moreno, Arnaud Lemmers, Thierry Gustot, Delphine Degre, Michael Adler and Heiner Wedemeyer

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23223

  20. Correction

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Injury and Regeneration
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Steatohepatitis/Metabolic Liver Disease
    15. Liver Biology/Pathobiology
    16. AASLD Practice Guidelines
    17. Rapid Communication
    18. Hepatology Elsewhere
    19. Image of the Month
    20. Correspondence
    21. Correction
    1. You have free access to this content
      Corrections (page 358)

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23475

    2. You have free access to this content
      Corrections (page 358)

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23498

SEARCH

SEARCH BY CITATION